Knight Therapeutics Stock
Your prediction
Knight Therapeutics Stock
There is no change in the price for Knight Therapeutics today.
Pros and Cons of Knight Therapeutics in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 0.000% | -1.639% | 3.448% | 57.068% | 61.290% | 84.049% | 77.515% |
| Biomark Diagnostics Inc. | 1.270% | -0.625% | 0.000% | 61.421% | 15.217% | 110.596% | 142.748% |
| MicroPlanet Technology Corp | -3.080% | 0.000% | 0.800% | -1.563% | -17.105% | -28.409% | -17.647% |
| Avricore Health Inc. | -10.530% | -10.526% | -19.048% | -42.045% | 10.870% | -74.752% | -78.017% |
News
Knight-Swift Transportation Q2 Earnings Call Highlights
Key Points
- Interested in Knight-Swift Transportation Holdings Inc.? Here are five stocks we like better.
- Knight-Swift said the truckload market tightened sharply in Q2 2026, with spot rates
Why Shares in Knight-Swift Transportation Crashed This Week
Knight-Swift Transportation (NYSE: KNX) is the largest full truckload carrier in the U.S., and it's always going to be at the center of the never-ending debate over where trucking companies are in
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief